Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
347
-
Total 13F shares, excl. options
-
179M
-
Shares change
-
+4.61M
-
Total reported value, excl. options
-
$12.9B
-
Value change
-
+$199M
-
Put/Call ratio
-
0.5
-
Number of buys
-
182
-
Number of sells
-
-192
-
Price
-
$72.47
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q1 2016
447 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q1 2016.
INCYTE CORP - COMMON STOCK (INCY) has 347 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179M shares
of 194M outstanding shares and own 92.32% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (25.5M shares), BAKER BROS. ADVISORS LP (23.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (16.1M shares), VANGUARD GROUP INC (11.6M shares), Capital World Investors (10.6M shares), Capital International Investors (5.42M shares), FMR LLC (4.87M shares), BlackRock Fund Advisors (4.02M shares), BlackRock Institutional Trust Company, N.A. (3.94M shares), and BB BIOTECH AG (3.84M shares).
This table shows the top 347 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.